Clinicopathologic study of 61 patients with ependymoma including MIB-1 immunohistochemistry

Annals of Diagnostic Pathology

Volumn 3, Issue 1, 1999, Pages 11-18

  Prayson, Richard A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Anaplastic ependymoma; Ependymoma; Glioma; Malignant ependymoma; MIB 1 antibody

Indexed keywords

CELL NUCLEUS ANTIGEN; KI 67 ANTIGEN; NUCLEAR PROTEIN; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOPSY; BRAIN TUMOR; BRAIN VENTRICLE; CHEMISTRY; CHILD; DISEASE COURSE; EPENDYMOMA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PRESCHOOL CHILD; SPINAL CORD TUMOR; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; ANTIGENS, NUCLEAR; BIOPSY; BRAIN NEOPLASMS; CEREBRAL VENTRICLES; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; EPENDYMOMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NUCLEAR PROTEINS; SPINAL CORD NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0033070484     PISSN: 10929134     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1092-9134(99)80004-5     Document Type: Article

References (3)

1. Rawlings CE III, Giangaspero F, Burger PC, et al: Ependymomas: A clinicopathologic study. Surg Neurol 1988;29:271-281
2. Cattoretti G, Becker MHG, Key G, et al: Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 an MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168:357-363
3. Karamitopoulou E, Perentes E, Diamantis I, et al: Ki-67 immunoreactivity in human central nervous system tumor: A study with MIB1 monoclonal on archival material. Acta Neuropathol 1994;87:47-54